The world's first wiki where authorship really matters (Nature Genetics, 2008). Due credit and reputation for authors. Imagine a global collaborative knowledge base for original thoughts. Search thousands of articles and collaborate with scientists around the globe.

wikigene or wiki gene protein drug chemical gene disease author authorship tracking collaborative publishing evolutionary knowledge reputation system wiki2.0 global collaboration genes proteins drugs chemicals diseases compound
Hoffmann, R. A wiki for the life sciences where authorship matters. Nature Genetics (2008)
MeSH Review

Vitreoretinopathy, Proliferative

Welcome! If you are familiar with the subject of this article, you can contribute to this open access knowledge base by deleting incorrect information, restructuring or completely rewriting any text. Read more.

Disease relevance of Vitreoretinopathy, Proliferative


High impact information on Vitreoretinopathy, Proliferative


Chemical compound and disease context of Vitreoretinopathy, Proliferative


Biological context of Vitreoretinopathy, Proliferative


Anatomical context of Vitreoretinopathy, Proliferative


Gene context of Vitreoretinopathy, Proliferative


Analytical, diagnostic and therapeutic context of Vitreoretinopathy, Proliferative


  1. A potential pathophysiologic role for alpha 2 beta 1 integrin in human eye diseases involving vitreoretinal traction. Kupper, T.S., Ferguson, T.A. FASEB J. (1993) [Pubmed]
  2. Liposome suppression of proliferative vitreoretinopathy. Rabbit model using antimetabolite encapsulated liposomes. Assil, K.K., Hartzer, M., Weinreb, R.N., Nehorayan, M., Ward, T., Blumenkranz, M. Invest. Ophthalmol. Vis. Sci. (1991) [Pubmed]
  3. Expression and upregulation of microtubule-associated protein 1B in cultured retinal pigment epithelial cells. Esser, P., Grisanti, S., Kociok, N., Abts, H., Hueber, A., Unfried, K., Heimann, K., Weller, M. Invest. Ophthalmol. Vis. Sci. (1997) [Pubmed]
  4. Aclacinomycin A in the treatment of experimental proliferative vitreoretinopathy. Efficacy and toxicity in the rabbit eye. Steinhorst, U.H., Chen, E.P., Hatchell, D.L., Samsa, G.P., Saloupis, P.T., Westendorf, J., Machemer, R. Invest. Ophthalmol. Vis. Sci. (1993) [Pubmed]
  5. Induction of arachidonic acid metabolite release by human fibroblasts in proliferative vitreoretinopathy. Kähler, C.M., Herold, M., Kaufmann, G., Pischel, A.B., Schratzberger, P., Reinisch, N., Gruber, B., Bellmann, R., Dunzendorfer, S., Kieselbach, G., Wiedermann, C.J. Eur. J. Pharmacol. (1998) [Pubmed]
  6. Increased vitreous concentrations of human hepatocyte growth factor in proliferative diabetic retinopathy. Nishimura, M., Ikeda, T., Ushiyama, M., Nanbu, A., Kinoshita, S., Yoshimura, M. J. Clin. Endocrinol. Metab. (1999) [Pubmed]
  7. Galectin-1 influences migration of retinal pigment epithelial cells. Alge, C.S., Priglinger, S.G., Kook, D., Schmid, H., Haritoglou, C., Welge-Lussen, U., Kampik, A. Invest. Ophthalmol. Vis. Sci. (2006) [Pubmed]
  8. Expression of PDGF and their receptors in human retinal pigment epithelial cells and fibroblasts: regulation by TGF-beta. Nagineni, C.N., Kutty, V., Detrick, B., Hooks, J.J. J. Cell. Physiol. (2005) [Pubmed]
  9. p38 MAPK mediates the expression of type I collagen induced by TGF-beta 2 in human retinal pigment epithelial cells ARPE-19. Kimoto, K., Nakatsuka, K., Matsuo, N., Yoshioka, H. Invest. Ophthalmol. Vis. Sci. (2004) [Pubmed]
  10. TGF-beta2-induced cell surface tissue transglutaminase increases adhesion and migration of RPE cells on fibronectin through the gelatin-binding domain. Priglinger, S.G., Alge, C.S., Neubauer, A.S., Kristin, N., Hirneiss, C., Eibl, K., Kampik, A., Welge-Lussen, U. Invest. Ophthalmol. Vis. Sci. (2004) [Pubmed]
  11. Intravitreal daunomycin induces multidrug resistance in proliferative vitreoretinopathy. Esser, P., Tervooren, D., Heimann, K., Kociok, N., Bartz-Schmidt, K.U., Walter, P., Weller, M. Invest. Ophthalmol. Vis. Sci. (1998) [Pubmed]
  12. Effects of fluorouracil and fluorouridine on protein synthesis in rabbit retina. Leon, J.A., Britt, J.M., Hopp, R.H., Mills, R.P., Milam, A.H. Invest. Ophthalmol. Vis. Sci. (1990) [Pubmed]
  13. Characterization of daunorubicin-induced apoptosis in retinal pigment epithelial cells: modulation by CD95L. Hueber, A., Weller, M., Welsandt, G., Kociok, N., Kirchhof, B., Esser, P. Invest. Ophthalmol. Vis. Sci. (2003) [Pubmed]
  14. The effect of combined daunorubicin and triamcinolone acetonide treatment on a refined experimental model of proliferative vitreoretinopathy. Chen, E.P., Steinhorst, U.H., Samsa, G.P., Saloupis, P.T., Hatchell, D.L. Invest. Ophthalmol. Vis. Sci. (1992) [Pubmed]
  15. Liposome suppression of proliferative vitreoretinopathy. Maurice, D. Invest. Ophthalmol. Vis. Sci. (1992) [Pubmed]
  16. Transferrin receptor expression by retinal pigment epithelial cells in proliferative vitreoretinopathy. Baudouin, C., Brignole, F., Fredj-Reygrobellet, D., Nègre, F., Bayle, J., Gastaud, P. Invest. Ophthalmol. Vis. Sci. (1992) [Pubmed]
  17. Vascular adhesion molecules in vitreous from eyes with proliferative diabetic retinopathy. Limb, G.A., Hickman-Casey, J., Hollifield, R.D., Chignell, A.H. Invest. Ophthalmol. Vis. Sci. (1999) [Pubmed]
  18. Adrenomedullin affects two signal transduction pathways and the migration in retinal pigment epithelial cells. Huang, W., Wang, L., Yuan, M., Ma, J., Hui, Y. Invest. Ophthalmol. Vis. Sci. (2004) [Pubmed]
  19. Genistein produces reduction in growth and induces apoptosis of rat RPE-J cells. Yoon, H.S., Rho, S.H., Jeong, J.H., Yoon, S., Yoo, K.S., Yoo, Y.H. Curr. Eye Res. (2000) [Pubmed]
  20. IL-10 in vivo gene expression in a cell-induced animal model of proliferative vitreoretinopathy. Bali, E., Willermain, F., Caspers-Velu, L., Dubois, C., Dehou, M.F., Velu, T., Libert, J., Bruyns, C. Int. J. Mol. Med. (2003) [Pubmed]
  21. Effect of NF-kappa B inhibition on TNF-alpha-induced apoptosis in human RPE cells. Yang, P., McKay, B.S., Allen, J.B., Jaffe, G.J. Invest. Ophthalmol. Vis. Sci. (2004) [Pubmed]
  22. Retina-specific expression of PDGF-B versus PDGF-A: vascular versus nonvascular proliferative retinopathy. Mori, K., Gehlbach, P., Ando, A., Dyer, G., Lipinsky, E., Chaudhry, A.G., Hackett, S.F., Campochiaro, P.A. Invest. Ophthalmol. Vis. Sci. (2002) [Pubmed]
  23. Verapamil inhibits proliferation, migration and protein kinase C activity in human retinal pigment epithelial cells. Hoffman, S., Gopalakrishna, R., Gundimeda, U., Murata, T., Spee, C., Ryan, S.J., Hinton, D.R. Exp. Eye Res. (1998) [Pubmed]
  24. Fibroblast growth-promoting activity in proliferative vitreoretinopathy: antagonism by acetylsalicylic acid. Kähler, C.M., Kieselbach, G.F., Reinisch, N., Troger, J., Göttinger, W., Wiedermann, C.J. Eur. J. Pharmacol. (1994) [Pubmed]
  25. Corticosteroids and daunomycin in the prevention of experimental proliferative vitreoretinopathy induced by macrophages. Hui, Y.N., Liang, H.C., Cai, Y.S., Kirchhof, B., Heimann, K. Graefes Arch. Clin. Exp. Ophthalmol. (1993) [Pubmed]
  26. Altered expression of keratin and vimentin in human retinal pigment epithelial cells in vivo and in vitro. Hunt, R.C., Davis, A.A. J. Cell. Physiol. (1990) [Pubmed]
  27. Immunoreactive ET-1 in the vitreous humor and epiretinal membranes of patients with proliferative vitreoretinopathy. Roldán-Pallarés, M., Rollín, R., Mediero, A., Martínez-Montero, J.C., Fernández-Cruz, A., Bravo-Llata, C., Fernández-Durango, R. Mol. Vis. (2005) [Pubmed]
  28. Effects of the matricellular protein SPARC on human retinal pigment epithelial cell behavior. Hagan, S., Hiscott, P., Sheridan, C.M., Wong, D., Grierson, I., McGalliard, J. Mol. Vis. (2003) [Pubmed]
  29. Localisation of vascular endothelial growth factor and its receptors to cells of vascular and avascular epiretinal membranes. Chen, Y.S., Hackett, S.F., Schoenfeld, C.L., Vinores, M.A., Vinores, S.A., Campochiaro, P.A. The British journal of ophthalmology. (1997) [Pubmed]
  30. Induction of interleukin-8 in human retinal pigment epithelial cells after denuding injury. Yoshida, A., Elner, S.G., Bian, Z.M., Elner, V.M. The British journal of ophthalmology. (2001) [Pubmed]
  31. Antiproliferative effect of retinoic acid in intravitreous silicone oil in an animal model of proliferative vitreoretinopathy. Araiz, J.J., Refojo, M.F., Arroyo, M.H., Leong, F.L., Albert, D.M., Tolentino, F.I. Invest. Ophthalmol. Vis. Sci. (1993) [Pubmed]
  32. Sustained delivery of retinoic acid from microspheres of biodegradable polymer in PVR. Giordano, G.G., Refojo, M.F., Arroyo, M.H. Invest. Ophthalmol. Vis. Sci. (1993) [Pubmed]
  33. Hepatocyte growth factor receptor in human RPE cells: implications in proliferative vitreoretinopathy. Lashkari, K., Rahimi, N., Kazlauskas, A. Invest. Ophthalmol. Vis. Sci. (1999) [Pubmed]
  34. Adjuvant 5-fluorouracil and heparin prevents proliferative vitreoretinopathy : Results from a randomized, double-blind, controlled clinical trial. Asaria, R.H., Kon, C.H., Bunce, C., Charteris, D.G., Wong, D., Khaw, P.T., Aylward, G.W. Ophthalmology (2001) [Pubmed]
  35. The effect of oral 13-cis-retinoic acid on retinal redetachment after surgical repair in eyes with proliferative vitreoretinopathy. Fekrat, S., de Juan, E., Campochiaro, P.A. Ophthalmology (1995) [Pubmed]
WikiGenes - Universities